Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Carlin

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
Penetrating the Barriers to Successful α-RadioimmunotherapySean Carlin
Seminars in Nuclear Medicine|February 24, 2015
Hypoxia imaging. Guest editorialSean Carlin, John Humm
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2012
PET of hypoxia: current and future perspectivesSean Carlin, John L Humm
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2003
In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporterSean Carlin, Gamal Akabani, Michael R Zalutsky
Nuclear Medicine and Biology|April 25, 2006
In vitro cytotoxicity of 211At-labeled trastuzumab in human breast cancer cell lines: effect of specific activity and HER2 receptor heterogeneity on survival fractionGamal Akabani, Sean Carlin, Phil Welsh, et al.
Nuclear Medicine and Biology|October 17, 2002
Sodium-iodide symporter (NIS)-mediated accumulation of [(211)At]astatide in NIS-transfected human cancer cellsSean Carlin, Robert J Mairs, Phil Welsh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 23, 2011
Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model systemCarola Heneweer, Jason P Holland, Vadim Divilov, et al.
International Journal of Radiation Oncology, Biology, Physics|June 26, 2012
Copper-64-diacetyl-bis(N(4)-methylthiosemicarbazone) pharmacokinetics in FaDu xenograft tumors and correlation with microscopic markers of hypoxiaKeisha C McCall, John L Humm, Rachel Bartlett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2014
A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracersSean Carlin, Hanwen Zhang, Megan Reese, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2025
Impact of peptidylarginine deiminase 4 (PAD4) deficiency in a fecal-induced peritonitis model of sepsisErblin Cani, Dhruva J Dwivedi, Sean Carlin, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
Penetrating the Barriers to Successful α-RadioimmunotherapySean Carlin
Seminars in Nuclear Medicine|February 24, 2015
Hypoxia imaging. Guest editorialSean Carlin, John Humm
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2012
PET of hypoxia: current and future perspectivesSean Carlin, John L Humm
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2003
In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporterSean Carlin, Gamal Akabani, Michael R Zalutsky
Nuclear Medicine and Biology|April 25, 2006
In vitro cytotoxicity of 211At-labeled trastuzumab in human breast cancer cell lines: effect of specific activity and HER2 receptor heterogeneity on survival fractionGamal Akabani, Sean Carlin, Phil Welsh, et al.
Nuclear Medicine and Biology|October 17, 2002
Sodium-iodide symporter (NIS)-mediated accumulation of [(211)At]astatide in NIS-transfected human cancer cellsSean Carlin, Robert J Mairs, Phil Welsh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 23, 2011
Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model systemCarola Heneweer, Jason P Holland, Vadim Divilov, et al.
International Journal of Radiation Oncology, Biology, Physics|June 26, 2012
Copper-64-diacetyl-bis(N(4)-methylthiosemicarbazone) pharmacokinetics in FaDu xenograft tumors and correlation with microscopic markers of hypoxiaKeisha C McCall, John L Humm, Rachel Bartlett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2014
A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracersSean Carlin, Hanwen Zhang, Megan Reese, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2025
Impact of peptidylarginine deiminase 4 (PAD4) deficiency in a fecal-induced peritonitis model of sepsisErblin Cani, Dhruva J Dwivedi, Sean Carlin, et al.
Pageof 5